BillionToOne · May 2026
Launched a non-invasive prenatal confirmation test using Fetal Cell Capture technology to bridge screening and invasive diagnostics.
The genetic testing platform detecting and measuring disease.
Company research
Public company, workplace, funding, and market signals
Updated Jul 28, 2026
Funding
Jun 2024 · Premji Invest
Follow-on equity / additional capital raise
Dec 2022 · Existing Series C investors (including Libertus Capital, Hummingbird Ventures, Baillie Gifford, Adams Street Partners, Neotribe Ventures, Fifty Years, Norwest Venture Partners, Time BioVentures)
Open Positions
97 jobs at BillionToOne
Clinical Laboratory Scientist, Oncology (Sunday AM Shift)
On-siteLab OperationsMenlo Park, CAToday
On-site